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Introduction
Tuberculosis (TB) is endemic in Taiwan; the incidence
in 2000 was reported to be 62.7/100,000 population,
which is an intermediate rate relative to the rest of the
world. Most of these cases presented as pulmonary TB
and TB pleuritis. Miliary peritoneal TB without
pulmonary manifestation is a rare presentation of
TB that can be confused with advanced ovarian cancer
if it is associated with ascites and elevated levels of
serum cancer antigen 125 (CA-125) [1]. Clinically, TB
peritonitis is generally characterized by abdominal
distension, anorexia, weight loss, fever, night sweats
and abdominal pain, although these typical symptoms
may be absent. Despite the introduction of effective
anti-TB chemotherapy, mortality from TB peritonitis
has remained high and may be related to the diagnostic
difficulty of this great mimicker. Clinicians should con-
sider peritoneal TB as part of the differential diagnosis
in women with nonspecific abdominal symptoms, un-
explained ascites, evidence of pelvic masses on imaging
studies, and elevated levels of CA-125.
Case Report
A 56-year-old woman was admitted to our hospital with
the chief complaints of severe abdominal fullness, poor
appetite, oligouria, chillness and abdominal pain for 20
SUMMARY
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days. She was a hospital attendant and had recently
taken care of a patient with lung infection. On admission,
she was afebrile and chest roentgenographic findings
were normal. However, abdominal sonography revealed
massive ascites and a huge pelvic complex mass.
Computed tomography (CT) scans showed ascites and
a 10 = 7 = 8 cm mixed soft tissue tumor arising from the
right ovary without lymphadenopathy. Laboratory
examinations for CA-199, carcinoembryonic antigen
and _-fetoprotein, liver function tests, and electrolyte
levels were all within normal ranges. Serum CA-125 was
abnormally high, with a level of 1,132.9 IU/mL (normal,
< 35 IU/mL).
Ultrasound-guided aspiration of the ascites was
performed. Ascitic fluid cytology was negative for
malignancy. White blood cell count was 1,791/L, of
which 98% were lymphocytes. Cultures for Mycobacterium
tuberculosis were negative for growth; Ziehl-Neelsen stains
were negative for acid-fast bacilli. Despite the negative
cytology for malignancy, there remained a strong
possibility of a malignant tumor arising from either the
pelvic tumor or the peritoneum, and a laparotomy was
arranged.
The laparotomy was performed through a midline
incision with the intention for primary debulking. A
5.2 L volume of ascitic fluid was removed and submitted
for cytologic examination. The peritoneum was inflamed,
with innumerable superficial whitish miliary deposits
measuring 1–3 mm in diameter on the peritoneal
surfaces, the uterus, the adnexa, the pouch of Douglas,
the serosal surfaces of the intestines, and on virtually
every visible intra-abdominal and pelvic surface (Figure
1). A large right ovarian cystic tumor measuring 15 =
14 = 10 cm in size was found and total oophorectomy
was performed. Deposits from the peritoneal surface
were sent for frozen-section analysis. Frozen section
of the ovarian tumor revealed mature cystic teratoma,
whereas other specimens from the peritoneum and
ovarian surface demonstrated a diffuse chronic granulo-
matous inflammation with central caseous necrosis
and no evidence of malignancy (Figure 2). These findings
were considered to be highly suggestive of TB. The
abdomen was closed.
The final histology report confirmed granulomatous
inflammation and central necrosis with areas of
caseation. The findings were compatible with TB.
Standard bacteriologic and mycologic cultures of the
ascitic fluid were sterile. No acid-fast bacilli were seen
by microscopy, and the results of TB polymerase chain
reaction (PCR) analysis of the specimens were negative.
The patient received quadruple anti-TB chemotherapy
immediately after surgery, with daily dosages of: 5
tablets Rifater (rifampicin 120 mg, isoniazid 80 mg,
pyrazinamide 250 mg), 1 g ethambutol, and 10 mg
pyridoxine (vitamin B6). The patient’s general condition
gradually improved over the next week and abdominal
fullness subsided. She was discharged and anti-TB drugs
were continued together with close monitoring of her
progress.
A few days later, it was noted that the patient’s liver
function was impaired. Alanine aminotransferase was
698 U/L (normal, 0–35 U/L). The quadruple anti-TB
regimen was discontinued, and her liver function
gradually improved over the next 2 weeks. Isoniazid and
ethambutol, followed by rifampicin, were gradually re-
introduced, with close monitoring of liver function.
During the next 4 months of follow-up, she was in good
condition and showed significant improvement.
Discussion
The incidence of extraperitoneal manifestations of TB
varies widely, and a normal chest X-ray does not exclude
Figure 1. Innumerable superficial miliary deposits on the
serosal surfaces of the intestines and ometum.
Figure 2. Chronic granulomatous inflammation with central
caseous necrosis.
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the diagnosis. This report strongly illustrates that
peritoneal TB should be included in the differential
diagnosis of all patients who present with ascites and
pelvic mass in spite of a negative chest X-ray finding.
In developed countries, TB is commonly detected
in immigrants, in patients with HIV infection,
accompanying alcoholic cirrhosis of the liver, and as a
complication of peritoneal dialysis. In developing
countries, TB is one of the most common causes of non-
cirrhotic ascites.
Peritoneal TB may mimic peritoneal carcinoma as it
usually presents with vague symptoms and non-specific
signs. Abdominal pain and malaise are the most frequent
symptoms, while ascites is the most frequent sign at
admission. CT imaging does not appear to be any more
specific than ultrasonography for the diagnosis of this
condition. Tumor markers such as CA-125 commonly
reach very high levels, especially in cases with exten-
sive miliary dissemination [1], and cannot aid in the
differential diagnosis. Simsek et al showed that serum
CA-125 level normalization correlated closely with the
response to anti-TB therapy [2], which indicates that
CA-125 could be used as a follow-up marker in patients
being treated for tuberculous peritonitis.
Ascites of TB peritonitis is exudative and is common-
ly misdiagnosed as carcinomatous peritonitis, especial-
ly in the elderly. Cell count analysis of ascitic fluid can
show either neutrophil or lymphocyte predominance.
Levels of total protein and lactate dehydrogenase, and
the serum/ascites glucose ratio in ascites fluid are usually
insufficient to distinguish TB peritonitis from peritoneal
carcinoma.
For a definitive diagnosis of tuberculous peritonitis,
it has long been recognized that microbiologic and/or
histologic confirmation is indicated. Direct smear for
Ziehl-Neelsen stains is unhelpful, with reported sensitivity
ranging from 0% [3] to 6% [4]. Culture of ascitic fluid
takes up a considerable amount of time before results
become available, and negative results occur in the
majority of tuberculous ascites. Hence, peritoneal biopsy
has a better diagnostic value than ascitic fluid analysis
alone. The typical TB granuloma consists of a focus of
epithelioid cells rimmed by fibroblasts, lymphocytes
and Langhans giant cells, and commonly presents with
central caseous necrosis.
With increasing incidence of TB epidemics, the low
sensitivity and the length of time taken by traditional
diagnostic modalities have hampered efforts to interrupt
disease transmission. Introduction of other noninvasive
diagnostic tools, such as ascitic adenosine deaminase
(ADA) levels, elevated interferon (IFN)-a concentrations,
and direct identification of M. tuberculosis with PCR
methods, has been suggested. In one series of 200
patients with undiagnosed ascites, laparoscopy proved
to be a safe method of providing a diagnosis [5]. Never-
theless, port site metastases may complicate the use of
laparoscopy in the diagnosis of ovarian cancer.
ADA was a helpful marker for tuberculous peritonitis;
levels in the ascitic fluid above 30 IU/mL had a sensitivity
and specificity of 94% and 92%, respectively [6]. How-
ever, false-negative results for ADA were quite common
in cirrhotic patients with low-protein ascites [7]. In
addition, ADA is a product of activated cells of the
immune system rather than of M. tuberculosis, so it may
be falsely positive in peritoneal carcinomas, spontaneous
bacterial peritonitis and secondary peritonitis. However,
in conditions that are difficult to diagnose, this easy,
rapid, safe and reliable test may have a place in routine
investigation.
IFN-a, a cytokine associated with a Th1 type of cell-
mediated immune response, has been found to be a
reliable indicator for the presence of peritoneal TB [8].
Elevated IFN-a concentrations in patients with tuber-
culous pleural and peritoneal effusions have been re-
ported in a number of studies [8,9]. This has led to the
proposal that IFN-a may be used as a diagnostic tool
for tuberculous exudates [10]. Use of a cut-off value of
* 3.2 U/mL has a sensitivity of 93% and a specificity of
98% [11].
Rapid nucleic acid amplification techniques such as
PCR allow direct identification of M. tuberculosis in clini-
cal specimens. The use of molecular techniques to assist
in the diagnosis of pulmonary TB is well accepted.
Molecular diagnosis of tuberculous peritonitis using
nucleic acid amplification tests has been reported [12].
However, PCR has limited sensitivity in detecting M.
tuberculosis due to lingering problems with specimen
preparation.
Close monitoring of anti-TB treatment is required
due to potential liver toxicity. If severe hepatitis is
present, then all hepatotoxic anti-TB drugs must be
temporarily discontinued and treatment changed to
non-hepatotoxic anti-TB drugs such as streptomycin,
ethambutol, and ofloxacin. When liver function returns
to normal, the hepatotoxic drugs may be re-introduced
one by one.
Nosocomial transmission of TB to two health care
workers after exposure to infected peritoneal fluid was
reported by Matlow et al [13]. If there is any evidence
of concomitant pulmonary TB, precautions against
airborne transmission are required, e.g. use of private
rooms, negative air pressure ventilation, respiratory
protective devices such as fitted respirator masks or
high-efficiency particulate air filters.
Tuberculous peritonitis is difficult to diagnose.
Identification of infected persons requires a high index
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of suspicion. Ascitic fluid ADA activity is a rapid and
reliable test for intra-abdominal TB. Peritoneal biopsy is
still the most reliable method for the diagnosis of TB
peritonitis. If laparotomy or laparoscopy is required for
making the diagnosis, frozen-section analysis should
always be considered, as extensive surgery prior to
adequate antimicrobial treatment in patients with
tuberculous peritonitis significantly increases post-
operative complications such as bladder and intes-
tinal fistula formation. More importantly, accurate
diagnosis can reduce future complications from this
infection and avoid unnecessary extensive surgery.
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